Physician profile
Mark L Prasarn
NPI 1750583910
$124,401.73
in general payments reported to CMS, 2019-2025
33 companies · $36K in 2025
The $36K reported for 2025 was more than what 94% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $6,908 · 2021: $4,016 · 2022: $15K · 2023: $8,144 · 2024: $37K · 2025: $36K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $33K · Consulting Fee: $25K · Travel and Lodging: $13K · Food and Beverage: $8,740.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $33,312.50 |
| Consulting Fee | $24,775.00 |
| Travel and Lodging | $13,357.32 |
| Food and Beverage | $8,740.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $43,855.50 | 2024-2025 | Zynrelef, Aponvie |
| Stryker Corporation | $39,145.42 | 2019-2023 | Yukon Oct Spinal System, Vitoss |
| Alphatec Spine, INC | $28,110.26 | 2022-2025 | Insignia Acp, Other - Miscellaneous, Safeop |
| Medinc of Texas | $2,180.13 | 2022-2025 | |
| Synthes Gmbh | $2,064.13 | 2024 | |
| Arthrex, INC. | $1,469.63 | 2023-2024 | |
| Medtronic, INC. | $1,441.77 | 2022-2025 | Mazor X System, Unid_pass, Anteralign Spinal System With Titan Nanolock Surface Technology |
| Depuy Synthes Sales INC. | $1,098.32 | 2022-2025 | Expedium, Symphony, Viper |
| Si-Bone, INC. | $807.07 | 2021-2025 | |
| Providence Medical Technology, INC. | $573.12 | 2022-2025 | |
| Medical Device Business Services, INC. | $472.80 | 2019 | |
| Carlsmed, INC. | $381.04 | 2022 | |
| Cerapedics INC. | $366.20 | 2022-2024 | I-Factor Peptide Enhanced Bone Graft |
| Amgen INC. | $235.43 | 2023 | Evenity |
| Osteocentric Technologies, INC. | $196.87 | 2023 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $194.49 | 2019 | |
| Seaspine Orthopedics Corporation | $155.94 | 2021 | |
| Zimmer Biomet Holdings, INC. | $155.33 | 2019 | |
| Kuros Biosciences USA, INC | $146.46 | 2021 | |
| Aesculap Implant Systems, LLC | $140.22 | 2024 | Activl |
| Spinal Simplicity, LLC | $137.63 | 2022 | |
| Centinel Spine, LLC | $135.37 | 2022 | |
| Sanara Medtech INC. | $128.70 | 2025 | Celleraterx |
| Ascendis Pharma Endocrinology INC | $125.00 | 2023 | |
| Biotronik Nro, INC. | $123.18 | 2025 | Prospera |
| Acacia Pharma INC | $123.05 | 2021 | |
| Smith+Nephew, INC. | $119.73 | 2022 | |
| Globus Medical, INC. | $114.26 | 2024 | Simplify Cervical Artificial Disc, Excelsiusgps Robotic Navigation System |
| Radius Health, INC. | $67.10 | 2024-2025 | Tymlos |
| Pacira Pharmaceuticals Incorporated | $63.34 | 2021-2023 | Iovera, Zilretta, Exparel |
| Ossur Americas, INC. | $35.56 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $24.68 | 2025 | |
| Carbofix Spine INC | $14.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Prasarn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.